Shares of Orchid Pharma surged as the company has got favourable USFDA inspection report for the facility.
The stock jumped by its daily limit of 19.9 per cent to Rs 21.35, highest since August 23.
The company has got a favourable inspection report from the USFDA for its active pharmaceutical ingredients manufacturing facility in Tamil Nadu. The report paves the way for exports from the plant.
Orchid Pharma stock posted biggest intraday percentage gain in over five months. About 1.9 million shares change hands, compared with 30-day average of 491,000 shares.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.